申请人:Janssen Pharmaceutica NV
公开号:US20200255401A1
公开(公告)日:2020-08-13
The invention relates to new quinoline, pyridopyrazine, naphthyridine and quinazolinone derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.